tradingkey.logo
tradingkey.logo
Search

Emergent BioSolutions Inc

EBS
Add to Watchlist
6.800USD
-0.220-3.13%
Close 09-18 16:00ET
347.81MMarket Cap
LossP/E TTM
After-hours 19:00 (ET)6.800USD-0.030-0.44%
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-3.13%

5 Days

+9.15%

1 Month

+45.92%

6 Months

-15.00%

Year to Date

-44.98%

1 Year

-14.36%

Key Figures

6.980Open
7.045High
352.70KVolume
LossP/E TTM
6.44P/E Dynamic
--Dividend TTM
0.69%Turnover Ratio
7.020Prev. Close
6.770Low
2.43MTurnover
LossP/E Static
1.02P/B
0.00%Div Yield TTM
-0.63%ROA
14.06052wk High
114.70Volume Ratio
-190.60MNet Profit
51.30MShares
-0.1358EPS TTM
2.34Beta
-1.60%ROE
4.36052wk Low
3.85%Amplitude
58.56%Gross Margin
347.81MMarket Cap
-11.33Reward/Risk
4.97%Risk Rate
Recent
Earnings
More news coming soon, stay tuned...

Emergent BioSolutions Inc's Score

0.12vs previous score
Forecast8.00
Financial Health8.13
Technical6.94
Valuation Dimensions8.23
Institutional Confidence7.00
Risk Assessment4.64

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
HoldCurrent Rating
11.000Target Price
+72.96%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy00000000
Buy22222222
Hold00000000
Sell00000000
Strong Sell00000000

Emergent BioSolutions Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Neutral

Summary

Neutral

Moving Average

Buy

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-3.49/0.11
Revenue / Forecast
234.30M/177.50M

Emergent BioSolutions Inc Profile

SectorPharmaceuticals
Ticker SymbolEBS
Number of employees900
CountryUnited States of America

Ownership

ShareholdersProportion
BlackRock Institutional Trust Company, N.A.7.60%
Dimensional Fund Advisors, L.P.5.34%
State Street Investment Management (US)5.23%
American Century Investment Management, Inc.4.73%
Shareholder TypesProportion
Investment Advisor37.35%
Investment Advisor/Hedge Fund31.07%
Hedge Fund8.77%
Research Firm3.93%

FAQs

What is the current price of Emergent BioSolutions Inc (EBS)?

The current price of Emergent BioSolutions Inc (EBS) is 6.80.

What is the symbol of Emergent BioSolutions Inc?

The ticker symbol of Emergent BioSolutions Inc is EBS.

What is the 52-week high of Emergent BioSolutions Inc?

The 52-week high of Emergent BioSolutions Inc is 14.06.

What is the 52-week low of Emergent BioSolutions Inc?

The 52-week low of Emergent BioSolutions Inc is 4.36.

What is the market capitalization of Emergent BioSolutions Inc?

The market capitalization of Emergent BioSolutions Inc is 347.81M.

Is Emergent BioSolutions Inc (EBS) currently rated as Buy, Hold, or Sell?

According to analysts, Emergent BioSolutions Inc (EBS) has an overall rating of signal_hold, with a price target of 11.00.

What is the Earnings Per Share (EPS TTM) of Emergent BioSolutions Inc (EBS)?

The Earnings Per Share (EPS TTM) of Emergent BioSolutions Inc (EBS) is -0.14.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.